CN Stock MarketDetailed Quotes

688578 Shanghai Allist Pharmaceuticals Co., Ltd.

Watchlist
  • 58.12
  • +0.77+1.34%
Market Closed May 31 15:00 CST
26.15BMarket Cap28.57P/E (TTM)

Shanghai Allist Pharmaceuticals Co., Ltd. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Shanghai Allist Pharmaceuticals Co., Ltd. Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 26, 2024

Revenue(YoY)

742.84M

+168.65%
EPS(YoY)

0.68

+750.00%
Analyst Rating

Strong Buy

May 31, 2024

Shanghai Allist Pharmaceuticals Co., Ltd. Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 3.646B--
--2024/FY-- / 2.961B--
--2023/FY2.012B / 1.777B--
--2021/FY530.094M / 614.000M--
--2020/FY560.900K / 600.000K--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 3.646B--
--2024/FY-- / 2.961B--
--2023/FY2.012B / 1.777B--
--2021/FY530.094M / 614.000M--
--2020/FY560.900K / 600.000K--

Shanghai Allist Pharmaceuticals Co., Ltd. Earnings Reports

  • Shanghai Alice Pharmaceutical Technology Co., Ltd. 2024 First Quarter Report

    Apr 25 12:00 ET

  • Summary of the 2023 Annual Report of Shanghai Alice Pharmaceutical Technology Co., Ltd.

    Apr 25 12:00 ET

  • Shanghai Alice Pharmaceutical Technology Co., Ltd. 2023 Annual Report

    Apr 25 12:00 ET

  • Shanghai Alice Pharmaceutical Technology Co., Ltd. 2023 Annual Results Express Announcement

    Feb 23 11:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: May 31, 2024

    Strong Buy

    • Strong Buy

      80.00%

    • Buy

      20.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg